U.S. Residential REITs Stock News

Acuity (AYI) has just approved a 17% increase in its quarterly dividend to US$0.20 per share, a move that puts income directly in focus for shareholders watching the stock’s return profile. See our latest analysis for Acuity. The dividend decision comes after a mixed share price run, with a 1-day share price return of 2.39% and 7-day share price return of 1.59% sitting against a 30-day share price return decline of 15.19%. The 5-year total shareholder return of 157.00% points to stronger long...

Scholar Rock Holding (SRRK) has attracted investor attention recently, with shares last closing at US$46.61 and total return over the past 3 months sitting at 66.17%, following multi year volatility. See our latest analysis for Scholar Rock Holding. The recent 1 day share price return of 5.12% and 30 day share price return of 8.90% sit within a much stronger 90 day share price return of 66.17%. At the same time, the 3 year total shareholder return of 278.33% contrasts with a 5 year total...

If you are wondering whether Modine Manufacturing's share price actually reflects its value, or if the market is getting ahead of itself, this article is designed to help you make sense of where things stand. The stock last closed at US$196.07, with returns of 32% over 7 days, 39.2% over 30 days, 39.2% year to date, 103.2% over 1 year, a very large return over 3 years of around 7x, and 1,224.8% over 5 years. This naturally raises questions about what is already priced in. Recent coverage...

Why Amalgamated Financial Has Drawn Fresh Attention Amalgamated Financial (AMAL) has attracted renewed investor interest after a strong recent run in the share price, shifting focus to how its current valuation lines up with its fundamentals and longer term return record. See our latest analysis for Amalgamated Financial. The recent 25.8% 1 month share price return, alongside a 46.7% 3 month share price move, sits against a 1 year total shareholder return of 21.8% and 5 year total shareholder...

In recent months, multiple Wall Street firms, including Goldman Sachs, UBS, Baird, Telsey Advisory Group, and Wells Fargo, have upgraded their views on Gap, signaling heightened analyst interest in the retailer’s prospects. This cluster of upgrades has shifted the broader analyst conversation around Gap, with more firms expressing constructive views on the company’s potential trajectory. With this wave of analyst upgrades shaping sentiment, we’ll now examine how it influences Gap’s...

Perella Weinberg Partners (NasdaqGS:PWP) has appointed Benjamin Port as a Partner to expand its Healthcare advisory practice. Port brings extensive experience in healthcare services advisory, adding depth to the firm's sector focused capabilities. For investors tracking NasdaqGS:PWP, the appointment comes with the shares around $22.11, after a 26.0% return over the past 30 days and year to date, and a 119.0% return over 3 years. Over 1 year, the stock shows a 10.5% decline, which contrasts...

Assessing Comerica after recent share performance Comerica (CMA) has seen mixed recent returns, with the stock roughly flat over the past month but showing a gain over the past 3 months. This helps put the current US$88.67 share price in context for investors. See our latest analysis for Comerica. While the 1 day and 7 day share price returns have recently moved lower, the 90 day share price return of 14.59% alongside a 1 year total shareholder return of 40.36% suggests momentum has generally...

This article walks through key clues in a clear, practical way for readers wondering whether Hess Midstream's share price reflects its true value, or if the market is mispricing its future potential. The stock last closed at US$34.97, with returns of 0.9% over 30 days, 0.9% year to date, an 8.8% decline over 1 year, and gains of 49.4% over 3 years and 135.1% over 5 years. Recent market attention on Hess Midstream has focused on how its fee based midstream model and long term contracts with...

Rithm Capital recently announced it is deepening its long-term partnership with Valon Technologies, with its Newrez unit set to deploy ValonOS to enhance servicing for over 4 million homeowners. This move highlights Rithm’s push to modernize mortgage servicing through AI-native technology, aiming to improve customer experience while trimming servicing costs. We’ll now examine how this AI-driven servicing upgrade shapes Rithm Capital’s broader investment narrative and long-term operational...

IDEXX Laboratories (IDXX) has just wrapped up FY 2025 with fourth quarter revenue of US$1,090.6 million and basic EPS of US$3.11, alongside trailing twelve month revenue of US$4.3 billion and EPS of US$13.17 that frame the latest print against a fuller year of performance. Over recent quarters the company has seen revenue move from US$954.3 million in Q4 2024 to just above US$1.1 billion in Q2 and Q3 2025, while quarterly EPS stepped from US$2.64 to a range between roughly US$3.0 and US$3.66,...

Napco Security Technologies (NSSC) just posted Q2 2026 results with revenue of US$48.2 million and basic EPS of US$0.38, alongside net income of US$13.5 million, putting fresh numbers on the table for investors tracking its profitability. The company has seen quarterly revenue move from US$42.9 million in Q2 2025 to US$48.2 million in Q2 2026, while basic EPS shifted from US$0.29 to US$0.38 over the same span. Trailing twelve month EPS stands at US$1.33 and net income at US$47.4 million,...

With no single headline event setting the tone today, Winnebago Industries (WGO) is drawing attention as investors weigh its recent share performance, current valuation signals, and the backdrop of its recreational vehicle and marine businesses. See our latest analysis for Winnebago Industries. Recent trading has been relatively steady, with a 30 day share price return of 12.83% and a 90 day gain of 27.54% from the current US$46.08 level. The 1 year total shareholder return of 3.12% contrasts...

How Tyson Foods' Latest Numbers Fit the Bigger Earnings Story Tyson Foods (TSN) has just reported its Q1 2026 results, with recent quarterly revenue ranging from about US$13.1b to US$13.9b and basic EPS between roughly US$0.02 and US$1.01, while trailing twelve month figures include total revenue of about US$54.4b and EPS of around US$1.33. Over the last few reported quarters, the company has seen revenue move from US$13.6b in Q1 2025 to US$13.9b in Q4 2025, with quarterly EPS shifting from...

Denali Therapeutics recently highlighted past and upcoming presentations of clinical and preclinical data for its Enzyme Transport Vehicle programs in rare lysosomal storage disorders, alongside an ongoing FDA Priority Review of tividenofusp alfa for Hunter syndrome with a decision expected by 5 April 2026. The FDA’s halt of a competing Hunter syndrome gene therapy trial has drawn attention to Denali’s ETV platform as a potential alternative approach for delivering enzyme replacement...

OpenText (NasdaqGS:OTEX) has appointed Ayman Antoun as Chief Executive Officer. The company has agreed to divest its Vertica business to concentrate on core cloud and AI offerings. These decisions were announced together, signaling a shift in leadership and portfolio focus. OpenText operates in enterprise information management, supplying software that helps large organizations manage content, security, and data across on-premises and cloud environments. The arrival of a new CEO with a...

Why SkyWest’s latest earnings matter for shareholders SkyWest (SKYW) just released fourth quarter and full year 2025 results, pairing higher revenue with slightly softer quarterly earnings per share. The company also locked in long term E175 flying agreements with United and Delta, which define its future cash flows. See our latest analysis for SkyWest. SkyWest’s latest earnings release and the confirmation of long term E175 contracts came alongside some share price volatility, with a 1 day...

Twist Bioscience (TWST) opened Q1 2026 with revenue of US$103.7 million and a basic EPS loss of US$0.50, while net income excluding extra items came in at a loss of US$30.5 million. The company reported revenue of US$84.7 million in Q4 2024, US$88.7 million in Q1 2025 and US$103.7 million in Q1 2026. Quarterly basic EPS ranged from a loss of US$0.59 in Q4 2024 to a profit of US$0.34 in Q3 2025 before returning to a loss of US$0.50 in the latest quarter. This keeps the focus on how efficiently...

Skyline Bankshares (SLBK) has capped FY 2025 with fourth quarter revenue of US$15.2 million and EPS of US$0.79, set against year over year earnings growth of 97.2% and a trailing net margin of 25.1%. The company has seen revenue move from US$45.6 million to US$57.3 million on a trailing twelve month basis, while EPS over the same span shifted from US$1.34 to US$2.84. This gives investors a clearer line of sight on how profitability is feeding through the income statement. With margins sitting...

Global Payments (NYSE:GPN) agreed to sell its issuer processing business as part of a two step transaction. At the same time, the company plans to acquire Worldpay, a major payments competitor, in a connected deal. The combined moves are described as reshaping Global Payments' core operations and targeting potential synergies for shareholders. For investors watching NYSE:GPN at around $71.99, this deal follows a difficult period for the stock, with a 1 year return of a 34.2% decline and a 5...

In late January 2026, S&T Bancorp’s board approved a US$0.36 per share quarterly cash dividend, modestly higher than the prior year, alongside reporting fourth-quarter 2025 results showing higher net interest income and earnings. The company paired this with a new US$100 million share repurchase authorization and ongoing branch expansion in Pittsburgh, underscoring management’s emphasis on capital returns while still investing in growth. Next, we’ll examine how the stronger net interest...

M/I Homes, Inc. reported past fourth-quarter and full-year 2025 results showing revenue of US$1,147.31 million and US$4,417.78 million, respectively, alongside lower net income and earnings per share than the previous year. The company also completed a share repurchase of 230,944 shares for US$30.37 million, highlighting ongoing capital return even as profitability softened. We will now examine how the earnings slowdown and completed buyback program shape M/I Homes’ investment narrative for...

Cheniere Energy Partners, L.P. recently declared a quarterly cash distribution of US$0.830 per common unit, comprising a US$0.775 base and a US$0.055 variable component, payable on February 13, 2026, to unitholders of record as of February 9, 2026. The blend of a recurring base payout with a smaller variable element highlights how the partnership balances ongoing income needs with flexibility around its liquefied natural gas export operations and tax considerations for foreign investors. We...

Collegium Pharmaceutical recently reported strong past revenue growth of 31.40%, supported by robust demand for its pain management products Xtampza ER and Belbuca and a focus on abuse-deterrent formulations. The company’s solid financial health and relatively low forward P/E of 5.71 have drawn increased analyst attention, highlighting its position within the healthcare sector’s pain management niche. Against this backdrop, we’ll examine how Collegium’s robust revenue expansion shapes its...

LivaNova (LIVN) is back on investor radars after KeyBanc Capital Markets shifted to a more favorable rating, linking the move to a broadly positive view on Medical Technology stocks. See our latest analysis for LivaNova. The upgrade comes after a period of rebuilding confidence, with the share price at US$65.71 and a 90 day share price return of 21.82% alongside a 1 year total shareholder return of 36.72%. This suggests momentum has picked up recently, even though longer term total...